Biology and chemoprevention of lung cancer

Chest

Volumn 113, Issue 1 SUPPL., 1998, Pages 40S-45S

  Siegfried, Jill M ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBENOXOLONE; CURCUMIN; EFLORNITHINE; ELLAGIC ACID; ENZYME INHIBITOR; ETRETINATE; FINASTERIDE; FUMARIC ACID; HORMONE ANTAGONIST; IBUPROFEN; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; ORNITHINE DECARBOXYLASE INHIBITOR; PIROXICAM; PRASTERONE; PROTEIN KINASE C INHIBITOR; RETINOID; RETINOL PALMITATE; S ALLYLCYSTEINE; TAMOXIFEN;

CANCER PREVENTION; CANCER RESEARCH; CHEMOPROPHYLAXIS; DRUG RESEARCH; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031985827     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.1_Supplement.40S     Document Type: Article

References (46)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization of oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6:963-68
2. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 1995; 37:37-43
3. Raunio H, Husgafvel-Pursianen K, Anttila S, et al. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 1995; 159:113-21
4. Aguayo SM. Determinants of susceptibility to cigarette smoke: potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodelling, and chronic airflow obstruction. Am J Respir Crit Care Med 1994; 149:1692-98
5. Gosney JR, Sissons M, Allibone R, et al. Pulmonary endocrine cells in chronic bronchitis and emphysema. J Pathol 1989; 147:127-33
6. Aguayo SM, Kane MA, King TE, et al. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 1989; 84: 1105-13
7. Aguayo SM, Miller YE, King TE. Idiopathic hyperplasia of pulmonary neuroendocrine cells. N Engl J Med 1993; 328: 581-82
8. Chen M, Diotavelli M, Kimizuka G, et al. Nicotine-induced neuroepithelial changes in young rabbits: a preliminary communication. Pediatr Pulmonol 1983; 1:303-08
9. Wang N, Cheng M, Sehraufnagel D. The cumulative scanning electron microscopic changes in baby mouse lungs following prenatal and postnatal exposures to nicotine. J Pathol 1984; 144:89-100
10. Benner SE, Lippman SM, Hong WK. Current status of retinoid chemoprevention of lung cancer. Oncology 1995; 9:205-09
11. Johnson BE, Linnoila RI, Williams JP, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995; 13:101-11
12. Bedi GC, Westra WH, Sidransky D. Multiple head and neck-tumors: independent events or clonal in origin [abstract]? Proc Am Assoc Cancer Res 1995; 36:640
13. Kanjilal S, Strom SS, Clayman GL, et al. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995; 55:3604-09
14. Sozzi G, Miozzo M, Pastorino U, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995; 55:135-40
15. Smith AL, Hung J, Walker L, et al. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br J Cancer 1996; 73:203-09
16. Kelloff GJK, Boone CW, Steele VE, et al. Progress in carreer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 1994; 54(suppl): 2015S-24S
17. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994; 12:851-73
18. Reddy BS, Nayini J, Tokumo K, et al. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 1990; 50:2562-68
19. Ratko TA, Detrisac CJ, Dinger NM, et al. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 1989; 49:4472-76
20. Szarka CE, Grana G, Engstrom PF. Chemoprevention of cancer. Curr Probl Cancer 1994; 18:6-79
21. Lam S, MacAulay C, Palcic B. Detection and localization of early lung cancer by imaging techniques. Chest 1993: 103(suppl):12S-14S
22. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994; 54:1634-37
23. Bennett WP, Colby TV, Travis WD, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993; 53:4817-22
24. Kishimoto Y, Sugio K, Hung JY, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small cell lung cancers. J Natl Cancer Inst 1995; 87: 1224-29
25. Sundaresan V, Ganly P, Hasleton P, et al. p53 and chromosome 3 abnormalities, characteristics of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992; 7:1989-97
26. Rabbitts P. Somatic genetic changes in lung cancer and precancerous lesions [abstract]. CCPC-93: Second International Cancer Chemoprevention Conference, Berlin, Germany, April 28-30, 1993
27. Voravud N, Shin DM, Ro JY, et al. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993; 53:2874-83
28. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor-α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993; 53:3579-84
29. Tockman MS, Erozan YS, Gupta P, et al. The early detection of second primary lung cancers by sputum immunostaining. Chest 1994; 106(suppl):385S-90S
30. Tockman MS, Gupta PK, Myers JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988; 6:1685-93
31. Aguayo SM, King TE Jr, Kane MA, et al. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. Cancer Res 1992; 52(suppl):2727S-31S
32. Kasprzyk PG, Sullivan TL, Hunt JD, et al. Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cell lines in the absence of erbB-2 gene amplification. Clin Cancer Res 1996; 2:75-80
33. Stich HF, Hornby AP, Mathew B, et al. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988; 40:93-101
34. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315:1501-05
35. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328:15-20
36. Costa A, Formelli F, Chiesa F, et al. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 1994; 54(suppl):2032S-37S
37. Bolla M, LeFur R, Ton Van J, et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx: results of a multicentric double-blind randomised study. Eur J Cancer 1994; 30: 767-72
38. Misset JL, Homasson JP, Santelli G, et al. Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment. Cancer Detect Prev 1986; 9:167-70
39. van Poppel G, Kok FJ, Hemus RJ. Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer 1992; 66:1164-68
40. Arnold AM, Browman GP, Levine MN, et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 1992; 65:737-43
41. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11:1216-22
42. Lee JS, Lippman SM, Benner SE, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994; 12:937-45
43. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35
44. McLarty JW, Holiday DB, Girard WM, et al. Beta-carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate end point study. Am J Clin Nutr 1995; 62(suppl):1431S-38S
45. Benner SE, Lippman SM, Hong WK. Chemoprevention of second primary tumours: a model for intervention trials. Eur J Cancer 1994; 30:727-29
46. Avis I, Mathias A, Unsworth EJ, et al. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ 1995; 6:485-92